Presbyopia Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight
(Albany, US) DelveInsight has launched a new report on "Presbyopia Market Insights, Epidemiology, and Market Forecast-2030".
DelveInsight's "Presbyopia
Market Insights, Epidemiology, and Market Forecast-2030" report
delivers an in-depth understanding of the Presbyopia , historical and
forecasted epidemiology as well as the Presbyopia market trends in the United
States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
·
It was estimated that there were 1.8 billion people
globally with presbyopia in 2015, 826 million of whom had near vision
impairment (VI) because they had no, or inadequate, vision correction.
·
The mean age of presbyopia was estimated to be
44.7±7.5 years and the male to female ratio was 1:2.2.
·
Expected launch of CSF-1 (Orasis Pharmaceuticals
Ltd), AGN 190584 (Allergan), and UNR844-Cl (Novartis Pharmaceuticals) shall
fuel the growth of the market during the forecast period i.e., 2017-2030.
Request for Free
Sample report: https://www.delveinsight.com/sample-request/presbyopia-market
View
Report: https://www.delveinsight.com/report-store/presbyopia-market
·
The report covers the descriptive overview of
Presbyopia, explaining its causes, signs and symptoms, pathophysiology,
diagnosis and currently available therapies
·
Comprehensive insight has been provided into the
Presbyopia epidemiology and treatment in the 7MM
·
Additionally, an all-inclusive account of both the
current and emerging therapies for Presbyopia are provided, along with the
assessment of new therapies, which will have an impact on the current treatment
landscape
·
A detailed review of Presbyopia market;
historical and forecasted is included in the report, covering drug outreach in
the 7MM
·
The report provides an edge while developing
business strategies, by understanding trends shaping and driving the global
Presbyopia market
“Presbyopia is more common in females as compared to the males.”
Request for Free
Sample report: https://www.delveinsight.com/sample-request/presbyopia-market
View
Report: https://www.delveinsight.com/report-store/presbyopia-market
Presbyopia is a vision condition in which the
shape of the crystalline lens of eye changes. These changes make it difficult
to focus on close objects. Presbyopia may seem to occur suddenly, but sight
reduction occurs over a number of years. Presbyopia usually becomes noticeable
in the early to mid-40s, but the reduction of accommodation starts as early as
childhood. Presbyopia is a natural part of the aging process of the eye. It is
not a disease, and it cannot be prevented.
Presbyopia is an age-related process and it is a gradual
thickening and loss of flexibility of the natural lens inside eye. These
age-related changes occur within the proteins in the lens, making the lens
harder and less elastic over time. Age-related changes also take place in the
muscle fibers surrounding the lens. With less elasticity, it gets difficult for
the eyes to focus on close objects. Signs and symptoms include: hard time
reading small print, having to hold reading material farther than arm’s
distance, problems seeing objects that are close, headaches and eye strain.
There are five types
of presbyopia:
·
Incipient
presbyopia: This is the very earliest stage, when it may be a bit more
difficult to read small print.
·
Functional
presbyopia: This occurs when patient begin to notice more problems with
near sight.
·
Absolute
presbyopia: If patient have this type, eyes cannot focus on near objects at
all.
·
Premature
presbyopia: This term is used when presbyopia occurs before the age of 40
years.
·
Nocturnal
presbyopia: When this occurs, focusing on near objects is particularly
difficult in low light conditions.
Request for Free
Sample report: https://www.delveinsight.com/sample-request/presbyopia-market
View
Report: https://www.delveinsight.com/report-store/presbyopia-market
Some of the Presbyopia
Companies:
·
Orasis Pharmaceuticals Ltd
·
Allergan
·
And Many Others
Presbyopia
Drugs Covered:
·
CSF-1
·
AGN 190584
·
And Many Others
Request for Free
Sample report: https://www.delveinsight.com/sample-request/presbyopia-market
View
Report: https://www.delveinsight.com/report-store/presbyopia-market
Table of Contents:
1. Key Insights
2. Executive Summary
of Presbyopia
3. Competitive
Intelligence Analysis for Presbyopia
4. Presbyopia :
Market Overview at a Glance
4.1. Presbyopia Total Market Share (%) Distribution in 2017
4.2. Presbyopia Total Market Share (%) Distribution in 2030
5. Presbyopia :
Disease Background and Overview
6. Patient Journey
7. Presbyopia
Epidemiology and Patient Population
8. Treatment
Algorithm, Current Treatment, and Medical Practices
8.1. Presbyopia Treatment and Management
8.2. Presbyopia Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of
Presbyopia Treatment
11. Marketed
Products
List to be continued in report
12. Emerging
Therapies
List to be continued in report
13. Presbyopia :
Seven Major Market Analysis
13.1. Key Findings
13.2. Presbyopia Market Size in 7MM
13.3. Presbyopia Market Size by Therapies in the 7MM
14. Attribute
analysis
15. 7MM: Market
Outlook
16. Access and
Reimbursement Overview of Presbyopia
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
20.1. Bibliography
20.2. Report Methodology
21. DelveInsight
Capabilities
22. Disclaimer
Related Reports:
About DelveInsight
DelveInsight is a
leading Life Science market research and business consulting company recognised
for its off-the-shelf syndicated market research reports as well as customised
solutions to firms in the healthcare sector.
Media Contact
Company Name: DelveInsight
Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment